• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Request Free Sample

    ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    South Korea Avian Influenza Vaccine Market

    ID: MRFR/Pharma/48045-HCR
    200 Pages
    Garvit Vyas
    September 2025

    South Korea Avian Influenza Vaccine Market Research Report By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines), By Administration Route (Intramuscular, Subcutaneous, Waterborne), By Target Species (Broilers, Layers, Breeders, Backyard Poultry) andBy Distribution Channel (Veterinary Clinics, Online Pharmacies, Retail Stores)- Forecast to 2035

    Share:

    Download PDF

    ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South Korea Avian Influenza Vaccine Market Research Report — Global Forecast till 2035 Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    South Korea Avian Influenza Vaccine Market Summary

    The South Korea Avian Influenza Vaccine market is projected to grow from 81 USD Million in 2024 to 156 USD Million by 2035.

    Key Market Trends & Highlights

    South Korea Avian Influenza Vaccine Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 6.14% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 156 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 81 USD Million, reflecting the current demand for avian influenza vaccines in South Korea.
    • Growing adoption of advanced vaccination technologies due to increasing awareness of avian influenza outbreaks is a major market driver.

    Market Size & Forecast

    2024 Market Size 81 (USD Million)
    2035 Market Size 156 (USD Million)
    CAGR (2025-2035) 6.14%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Merial, Vaxxinova, Chengdu Hualong Biotechnology, University of Queensland, CSL Limited, Hester Biosciences, Zoetis, Lallemand Animal Nutrition, Boehringer Ingelheim, Yuhuan Burgeon Animal Health, Cegelec, Nantong Lianda Biological, Oklahoma State University, HyLife

    South Korea Avian Influenza Vaccine Market Trends

    Driven by the ongoing danger of avian influenza outbreaks, the South Korea Avian Influenza Vaccine Market is seeing an increasing emphasis on biosecurity practices in the poultry industry. To improve the monitoring of chicken farms, the South Korean government is progressively enforcing tighter rules, which thus calls for the creation and use of potent vaccinations. Especially given that chicken is a major component of South Korea's agricultural exports, key market drivers include the necessity for preserving food safety and safeguarding the poultry sector.

    Furthermore, the improvement of vaccination technology for example, the creation of more efficient and quick-response vaccines against many types of avian influenza would help to open possibilities in this sector. Partnerships between pharmaceutical corporations and research universities might provide creative answers for new viral types. Farmers' desire to avoid losses from disease outbreaks while following government rules will drive the need for successful immunization programs.

    Recent developments include a move toward more integrated disease management strategies, integrating vaccination with additional control measures like enhanced biosecurity policies and public awareness initiatives. The South Korean government is also giving more attention to funding veterinary public health projects, which supports a more robust chicken industry. Aiming to guarantee timely access to vaccinations, the inclusion of technology developments in vaccine manufacturing and distribution is also becoming more popular. Regulatory backing and the ongoing development of avian influenza threats will drive the general expansion of the South Korea Avian Influenza Vaccine Market, which is overall set to rise.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    South Korea Avian Influenza Vaccine Market Drivers

    Market Segment Insights

    Avian Influenza Vaccine Market Vaccine Type Insights

    The South Korea Avian Influenza Vaccine Market encompasses various vaccine types that play critical roles in disease prevention and management in poultry. Among these, Live Attenuated Vaccines are particularly noted for their ability to induce a strong immune response, making them a preferred choice in various vaccination programs. These vaccines allow for broader immunological coverage, which is vital, especially in high-density poultry farming regions in South Korea.

    Inactivated Vaccines, on the other hand, have gained prominence due to their safety profile and reliability. They are especially favored in scenarios where live vaccines could evoke concerns regarding reversion to virulence. As the country is a major hub for poultry production, the demand for these inactivated formulations is significant, aligning with the industry’s need for sustainable health management practices.

    Recombinant Vaccines represent an innovative approach within the South Korea Avian Influenza Vaccine Market, utilizing genetic engineering techniques to enhance efficacy while maintaining safety. These vaccines have the potential to rapidly adapt to emerging strains of the virus, making them a timely solution in the face of evolving pathogens. This adaptability is vital in countries like South Korea, where the poultry industry is susceptible to outbreaks of avian influenza.

    Lastly, Subunit Vaccines are increasingly recognized for their ability to trigger a targeted immune response without the use of live pathogens. This makes them an attractive option in biosecurity-focused environments, thereby contributing to a secure poultry sector. The South Korea Avian Influenza Vaccine Market data reflects a strategical transition towards vaccines that promote better biosecurity measures, indicating a growth trajectory influenced by both advancements in veterinary medicine and increased awareness of disease management among poultry farmers.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Avian Influenza Vaccine Market Administration Route Insights

    The South Korea Avian Influenza Vaccine Market showcases diversified Administration Routes essential for effective immunization strategies. Among these, Intramuscular and Subcutaneous routes are widely used in veterinary practices, given their efficiency in delivering vaccines directly into muscle tissue or just beneath the skin. This direct administration efficiently mobilizes immune responses, thereby ensuring quicker protection for avian species against avian influenza.

    The Waterborne route also plays a significant role by allowing mass vaccinations through the animals' drinking water, which is particularly advantageous in poultry farming due to its convenience and low stress on birds during administration. Each method has its own advantages and is strategically utilized based on the specific needs of different avian populations. The ongoing growth of the South Korea Avian Influenza Vaccine Market is driven by an increase in poultry farming and the need for biosecurity measures, highlighting the importance of these Administration Routes in safeguarding poultry against influenza outbreaks.

    Overall, the segmentation in this market reflects the demand for effective and accessible vaccination methods to combat avian diseases.

    Avian Influenza Vaccine Market Target Species Insights

    The South Korea Avian Influenza Vaccine Market, focusing on Target Species, reveals significant trends and opportunities across various categories such as Broilers, Layers, Breeders, and Backyard Poultry. Broilers and Layers comprise a substantial portion of avian production in South Korea, thus necessitating comprehensive vaccination strategies to prevent outbreaks that could affect poultry health and production efficiency.

    Breeders are essential as they are responsible for the genetic stock necessary for both Broilers and Layers, emphasizing the need for their protection against avian influenza to ensure a sustainable poultry industry. Meanwhile, the Backyard Poultry segment continues to grow in importance, often representing a key source of livelihood for many rural households. This segment’s vulnerability to avian diseases highlights the necessity of effective vaccination strategies to protect local farmers and their incomes.

    With heightened awareness and regulatory support for biosecurity measures, the focus on vaccines for these Target Species is expected to enhance the overall resilience of the poultry industry in South Korea, leading to improved public health outcomes and economic stability.

    Avian Influenza Vaccine Market Distribution Channel Insights

    In the South Korea Avian Influenza Vaccine Market, the Distribution Channel segment plays a crucial role in ensuring effective vaccine accessibility and delivery. Veterinary Clinics are significant distribution points, as they provide specialized care and guidance to poultry farmers, thereby fostering trust and consistent usage of vaccines among livestock producers. Meanwhile, Online Pharmacies have emerged as an increasingly popular channel due to their convenience and the growing trend of digital health services within South Korea, making vaccines easy to obtain without geographical limitations.

    Retail Stores also facilitate the distribution of avian influenza vaccines, catering to local farmers and individuals with immediate needs, thereby enhancing vaccine availability in rural areas. The synergy among these channels not only streamlines the supply chain but also aligns with South Korea's focus on biosecurity and public health. Overall, the effective interplay of these distribution channels is essential for maintaining robust vaccine coverage, addressing outbreaks promptly, and ensuring the safety of poultry populations, which is vital to the agriculture sector in South Korea.

    As the market evolves, these channels are expected to adapt to consumer behavior shifts, presenting opportunities for innovative distribution strategies.

    Get more detailed insights about South Korea Avian Influenza Vaccine Market Research Report — Global Forecast till 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The South Korea Avian Influenza Vaccine Market is characterized by its dynamic landscape, shaped by a need for innovative solutions to combat avian influenza outbreaks among poultry populations. This market has seen significant consolidation and exploration of partnerships among manufacturers, as stakeholders strive to enhance their product offerings and expand their market reach. The increasing concerns over biosecurity, coupled with stricter regulatory frameworks, have motivated companies to invest heavily in research and development.

    Consequently, the competitive environment is influenced by both local players and international firms that seek to capitalize on the growing demand for effective vaccination solutions against avian influenza. Merial has established a prominent presence in the South Korean Avian Influenza Vaccine Market, recognized for its advanced vaccine formulations tailored to the needs of poultry producers in the region. The company's strength lies in its consistent investment in research, enabling it to provide high-quality products that meet the rigorous approval standards set by local authorities.

    Merial's dedication to biosecurity solutions has positioned it as a trusted partner for poultry farmers, contributing significantly to disease control efforts in South Korea. The company's reputation for reliability and efficacy in its vaccine offerings further solidifies its competitive stance in the market. Vaxxinova, another key player in the South Korean Avian Influenza Vaccine Market, specializes in developing innovative vaccines that are crucial for the health and productivity of poultry. The company boasts a diverse portfolio of avian vaccines and has made significant investments in collaborative research projects to enhance its product range.

    Vaxxinova's strengths include its ability to leverage advanced technologies and its strong distribution network, ensuring its products are accessible to poultry producers across South Korea. Notably, Vaxxinova has pursued strategic mergers and acquisitions to expand its technological capabilities and market presence. These initiatives have been instrumental in reinforcing the company's foothold in the competitive landscape, allowing it to respond effectively to the evolving needs of the market while maintaining a focus on quality and customer satisfaction.

    Key Companies in the South Korea Avian Influenza Vaccine Market market include

    Industry Developments

    Market Segmentation

    Avian Influenza Vaccine Market Vaccine Type Outlook

    • Live Attenuated Vaccines
    • Inactivated Vaccines
    • Recombinant Vaccines
    • Subunit Vaccines

    Avian Influenza Vaccine Market Target Species Outlook

    • Broilers
    • Layers
    • Breeders
    • Backyard Poultry

    Avian Influenza Vaccine Market Administration Route Outlook

    • Intramuscular
    • Subcutaneous
    • Waterborne

    Avian Influenza Vaccine Market Distribution Channel Outlook

    • Veterinary Clinics
    • Online Pharmacies
    • Retail Stores

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 79.0(USD Million)
    MARKET SIZE 2024 81.0(USD Million)
    MARKET SIZE 2035 156.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.139% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Merial, Vaxxinova, Chengdu Hualong Biotechnology, University of Queensland, CSL Limited, Hester Biosciences, Zoetis, Lallemand Animal Nutrition, Boehringer Ingelheim, Yuhuan Burgeon Animal Health, Cegelec, Nantong Lianda Biological, Oklahoma State University, HyLife
    SEGMENTS COVERED Vaccine Type, Administration Route, Target Species, Distribution Channel
    KEY MARKET OPPORTUNITIES Increasing poultry production demand, Government funding for vaccination programs, Rising awareness of biosecurity measures, Enhancements in vaccine technology, Growing exports of poultry products
    KEY MARKET DYNAMICS rising poultry production, government vaccination programs, increasing disease outbreaks, regulatory compliance challenges, growing import demand
    COUNTRIES COVERED South Korea

    Market Highlights

    Author

    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Get In Touch

    Leave a Comment

    FAQs

    What is the projected market size of the South Korea Avian Influenza Vaccine Market in 2024?

    The South Korea Avian Influenza Vaccine Market is projected to be valued at 81.0 million USD in 2024.

    What is the expected market size of the South Korea Avian Influenza Vaccine Market by 2035?

    By 2035, the market is expected to reach a valuation of 156.0 million USD.

    What is the expected CAGR for the South Korea Avian Influenza Vaccine Market from 2025 to 2035?

    The expected CAGR for this market is 6.139% from 2025 to 2035.

    What are the key players currently dominating the South Korea Avian Influenza Vaccine Market?

    Major players include Merial, Vaxxinova, Boehringer Ingelheim, and Zoetis.

    Which vaccine type holds the largest market value in 2024 within the South Korea Avian Influenza Vaccine Market?

    In 2024, Inactivated Vaccines hold the largest market value at 25.0 million USD.

    How much is the market value of Live Attenuated Vaccines in the South Korea Avian Influenza Vaccine Market for 2024?

    The market value for Live Attenuated Vaccines in 2024 is estimated at 15.0 million USD.

    What is the projected market value for Subunit Vaccines in 2035 within the South Korea Avian Influenza Vaccine Market?

    By 2035, the market value for Subunit Vaccines is expected to reach 36.0 million USD.

    What are the growth drivers for the South Korea Avian Influenza Vaccine Market?

    The growth drivers include rising poultry production and increased awareness of avian diseases.

    Are there any emerging trends in the South Korea Avian Influenza Vaccine Market?

    Emerging trends include the development of recombinant vaccines and advancements in vaccine technology.

    What market challenges are anticipated for the South Korea Avian Influenza Vaccine Market?

    Challenges include regulatory constraints and the need for efficient distribution channels.

    1. |- Table of Contents       EXECUTIVE SUMMARY Market Overview Key Findings Market Segmentation Competitive Landscape Challenges and Opportunities Future Outlook     MARKET INTRODUCTION Definition Scope of the study Research Objective Assumption Limitations RESEARCH METHODOLOGY Overview Data Mining Secondary Research Primary Research Primary Interviews and Information Gathering Process Breakdown of Primary Respondents Forecasting Model Market Size Estimation Bottom-Up Approach Top-Down Approach Data Triangulation Validation     MARKET DYNAMICS Overview Drivers Restraints Opportunities MARKET FACTOR ANALYSIS Value chain Analysis Porter's Five Forces Analysis Bargaining Power of Suppliers Bargaining Power of Buyers Threat of New Entrants Threat of Substitutes Intensity of Rivalry COVID-19 Impact Analysis Market Impact Analysis Regional Impact Opportunity and Threat Analysis     South Korea Avian Influenza Vaccine Market, BY Vaccine Type (USD Million) Live Attenuated Vaccines Inactivated Vaccines Recombinant Vaccines Subunit Vaccines South Korea Avian Influenza Vaccine Market, BY Administration Route (USD Million) Intramuscular Subcutaneous Waterborne South Korea Avian Influenza Vaccine Market, BY Target Species (USD Million) Broilers Layers Breeders Backyard Poultry South Korea Avian Influenza Vaccine Market, BY Distribution Channel (USD Million) Veterinary Clinics Online Pharmacies Retail Stores     Competitive Landscape Overview Competitive Analysis Market share Analysis Major Growth Strategy in the Avian Influenza Vaccine Market Competitive Benchmarking Leading Players in Terms of Number of Developments in the Avian Influenza Vaccine Market Key developments and growth strategies New Product Launch/Service Deployment Merger & Acquisitions Joint Ventures Major Players Financial Matrix Sales and Operating Income Major Players R&D Expenditure. 2023 Company Profiles Merial Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies Vaxxinova Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies Chengdu Hualong Biotechnology Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies University of Queensland Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies CSL Limited Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies Hester Biosciences Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies Zoetis Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies Lallemand Animal Nutrition Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies Boehringer Ingelheim Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies Yuhuan Burgeon Animal Health Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies Cegelec Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies Nantong Lianda Biological Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies Oklahoma State University Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies HyLife Financial Overview Products Offered Key Developments SWOT Analysis Key Strategies Appendix References Related Reports LIST Of tables   LIST OF ASSUMPTIONS South Korea Avian Influenza Vaccine Market SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD Billions) South Korea Avian Influenza Vaccine Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions) South Korea Avian Influenza Vaccine Market SIZE ESTIMATES & FORECAST, BY TARGET SPECIES, 2019-2035 (USD Billions) South Korea Avian Influenza Vaccine Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions) PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL ACQUISITION/PARTNERSHIP                                                           LIST Of figures   MARKET SYNOPSIS SOUTH KOREA AVIAN INFLUENZA VACCINE MARKET ANALYSIS BY VACCINE TYPE SOUTH KOREA AVIAN INFLUENZA VACCINE MARKET ANALYSIS BY ADMINISTRATION ROUTE SOUTH KOREA AVIAN INFLUENZA VACCINE MARKET ANALYSIS BY TARGET SPECIES SOUTH KOREA AVIAN INFLUENZA VACCINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL KEY BUYING CRITERIA OF AVIAN INFLUENZA VACCINE MARKET RESEARCH PROCESS OF MRFR DRO ANALYSIS OF AVIAN INFLUENZA VACCINE MARKET DRIVERS IMPACT ANALYSIS: AVIAN INFLUENZA VACCINE MARKET RESTRAINTS IMPACT ANALYSIS: AVIAN INFLUENZA VACCINE MARKET SUPPLY / VALUE CHAIN: AVIAN INFLUENZA VACCINE MARKET AVIAN INFLUENZA VACCINE MARKET, BY VACCINE TYPE, 2025 (% SHARE) AVIAN INFLUENZA VACCINE MARKET, BY VACCINE TYPE, 2019 TO 2035 (USD Billions) AVIAN INFLUENZA VACCINE MARKET, BY ADMINISTRATION ROUTE, 2025 (% SHARE) AVIAN INFLUENZA VACCINE MARKET, BY ADMINISTRATION ROUTE, 2019 TO 2035 (USD Billions) AVIAN INFLUENZA VACCINE MARKET, BY TARGET SPECIES, 2025 (% SHARE) AVIAN INFLUENZA VACCINE MARKET, BY TARGET SPECIES, 2019 TO 2035 (USD Billions) AVIAN INFLUENZA VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2025 (% SHARE) AVIAN INFLUENZA VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2035 (USD Billions) BENCHMARKING OF MAJOR COMPETITORS  

    South Korea Avian Influenza Vaccine Market Segmentation

     

     

     

    • Avian Influenza Vaccine Market By Vaccine Type (USD Million, 2019-2035)

      • Live Attenuated Vaccines
      • Inactivated Vaccines
      • Recombinant Vaccines
      • Subunit Vaccines

     

    • Avian Influenza Vaccine Market By Administration Route (USD Million, 2019-2035)

      • Intramuscular
      • Subcutaneous
      • Waterborne

     

    • Avian Influenza Vaccine Market By Target Species (USD Million, 2019-2035)

      • Broilers
      • Layers
      • Breeders
      • Backyard Poultry

     

    • Avian Influenza Vaccine Market By Distribution Channel (USD Million, 2019-2035)

      • Veterinary Clinics
      • Online Pharmacies
      • Retail Stores

     

     

     

     

     

     

    Report Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027